Showing results 5 to 6 of 6
< previous
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
Safety, pharmacokinetics, and antiviral effects of ABI-H0731, a hepatitis B virus core inhibitor: a randomised, placebo-controlled phase 1 trial Journal:The Lancet Gastroenterology & Hepatology | 2020 | 31 | ||
2019 | 29 |